If Congress overreaches and bans or generates significant uncertainty regarding the legitimacy of decisions to customize individual OTC derivatives transactions there will be enormous negative implications on how companies manage risk.
Editor's note · Context
Warns against overregulation that could harm companies' risk management strategies.
Share
More from Mike Crapo
we spent a lot of time this week talking about the problems of our healthcare system: Premiums are rising; hospitals are struggling; and out-of-pocket costs are out of control. These problems are not new. And, frankly, notwithstanding all…
more of the politics of fear. Rural hospitals and providers not only deliver essential healthcare services in their communities but also strengthen local economies, employing hundreds of individuals and supporting regional business…
Codifying the Department of Labor’s recent updates to the AEWR would help clarify and stabilize wages in the H-2A agricultural labor program.
Idahoans were unfairly left out of the RECA program for far too long. I was proud we finally secured coverage for victims in the program’s reauthorization signed into law last year.





